All stock lists
BioStem Technologies, Inc. (NASDAQ:BSEM)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
1.52-0.04 (-2.87%)
Insider Score
––Not scored
BSEM Insider Score
Insiders here have filed 17 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
BSEM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 7.90 M | 6.14 M | -84.82 M | 10.47 M | 49.30 M | 72.53 M |
| Revenue Growth (YoY) | -83.98 % | -91.54 % | -182.45 % | -87.31 % | -33.82 % | 73.08 % |
| Cost of Revenue | 3.75 M | 2.92 M | 461.45 K | 1.26 M | 685.18 K | 853.44 K |
| Gross Profit | 4.15 M | 3.22 M | -85.28 M | 9.21 M | 48.61 M | 71.67 M |
| SG&A Expense | 11.82 M | 10.97 M | -79.14 M | 5.80 M | 46.48 M | 64.68 M |
| R&D Expense | 733.62 K | 1.14 M | 1.48 M | 1.96 M | 1.96 M | 1.69 M |
| Operating Expenses | 12.55 M | 12.10 M | -77.78 M | 7.76 M | 48.50 M | 66.43 M |
| Operating Income | -8.40 M | -8.88 M | -7.50 M | 1.45 M | 112.76 K | 5.25 M |
| Pretax Income | -8.97 M | -8.82 M | -7.32 M | 1.47 M | 177.95 K | 5.28 M |
| Tax Provision | 0.00 | 0.00 | 3.94 M | 707.68 K | 742.31 K | 797.44 K |
| Net Income | -8.97 M | -8.82 M | -11.26 M | 761.05 K | -564.36 K | 4.48 M |
| EPS (Basic) | -0.52 | -0.52 | -0.67 | 0.05 | -0.03 | 0.27 |
| EPS (Diluted) | -0.52 | -0.52 | -0.67 | 0.03 | -0.02 | 0.17 |
| Shares Outstanding | 17.33 M | 16.85 M | 16.73 M | 16.75 M | 16.71 M | 16.57 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.